Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
carboplatin paclitaxel bevacizumab
DRUG
2 trials
Sponsors
Dutch Society of Physicians for Pulmonology and Tuberculosis
, Gruppo Oncologico Italia Meridionale
Conditions
Non Small Cell Lung Cancer
Non-squamous Nonsmall Cell Neoplasm of Lung
Phase 2
Paclitaxel-Carboplatin-Bevacizumab +/- Nitroglycerin in Metastatic Non-Squamous-Non-Small Cell Lung Cancer
Completed
NCT01171170
Dutch Society of Physicians for Pulmonology and Tuberculosis
Non Small Cell Lung Cancer
Start: 2011-01-31
End: 2020-08-31
Updated: 2020-09-28
Phase 3
Quality of Life Comparison in Advanced Non-squamous Non Small Cell Lung Cancer
NCT01303926
Gruppo Oncologico Italia Meridionale
Non-squamous Nonsmall Cell Neoplasm of Lung
Start: 2010-01-31
End: 2012-06-30
Target: 118
Updated: 2012-04-10
Related Papers
Nitroglycerin as a radiosensitizer in non-small cell lung cancer: Results of a prospective imaging-based phase II trial.
2019-12-13
12 citations
Can radiomics help to predict skeletal muscle response to chemotherapy in stage IV non-small cell lung cancer?
2019-09-09
24 citations
The prognostic value of early onset, CT derived loss of muscle and adipose tissue during chemotherapy in metastatic non-small cell lung cancer.
2019-05-20
28 citations
Paclitaxel/ carboplatin/ bevacizumab in non-small cell lung cancer patients induces peripheral effector CD8 T cell proliferation that could be prone for treatment with checkpoint inhibitors
Annals of Oncology
2019-04-01
3 citations
What you see is (not) what you get: tools for a non-radiologist to evaluate image quality in lung cancer.
2018-07-18
1 citations
[18F]FDG PET/CT-based response assessment of stage IV non-small cell lung cancer treated with paclitaxel-carboplatin-bevacizumab with or without nitroglycerin patches.
2016-09-06
13 citations
A randomized phase II study of paclitaxel-carboplatin-bevacizumab (PCB) with or without nitroglycerin patches (NTG) in patients (pts) with stage IV nonsquamous non-small cell lung cancer (NSCLC): Nvalt 12 (NCT01171170).
Journal of Clinical Oncology
2014-05-20
3 citations